Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018162564> ?p ?o ?g. }
- W2018162564 endingPage "380" @default.
- W2018162564 startingPage "369" @default.
- W2018162564 abstract "This was an open-label study in 19 children aged 9–13 years, weighing 27–44 kg, with bronchial asthma. Twenty-four-hour steady-state concentrations of theophylline and its metabolites 1,3-dimethyl uric acid, 3-methyl xanthine and 1-methyl uric acid were assessed after daily dosing of 600 mg (ca18 mg/kg/day) of the sustainedrelease theophylline micro-pellet sprinkle system BY158K, for 4 days. The dosing regimen used was an unequal twice-daily dose of 200 mg in the morning after breakfast and 400 mg in the evening after dinner. Twenty-four-hour peak expiratory flow (PEF) profiles were compared before treatment and at steady-state, along with lung function parameters after bronchial provocation. Mean values±SD (n=16) of the steady-state characteristics were Cmin6.8±2.1 mg/1, Cmax14.5±4.8 mg/1 and Cav10.S±2.9 mg/1, the plateau time was 11.7±4.8 hr and peak-trough fluctuation and swing were 72±21 and 118±52%, respectively. There was an excellent reproducibility of theophylline pre-dose levels at corresponding time points of the 24-hr sampling period [r=0.864 (p< 0.001)]. Mean values±SD of the 24 hr average serum metabolite levels were 0.9±0.2 mg/1 for 1, 3-dimethyl uric acid, 0.6±0.1 mg/1 for 3-methyl xanthine and 0.4±0.1 mg/1 for 1-methyl uric acid. Lung function (n=17) following bronchial provocation, improved in 10 children after theophylline treatment of 4 days, remained stable in 2 patients and deteriorated in 5 patients. Serum theophylline profiles and PEF profiles ran largely in parallel over the 24-hr period. Six children exhibited typical theophylline induced side-effects, headache (n=3), nausea (n=4), dizziness (n=l), vomiting (n=4), sleep disturbances (n=1), pallor (n=1) and tremor(n=1), necessitating in 3 children one dose omission/reduction (n=2) or subsequent dose reduction (n=1). It has been shown that a twice daily dosing regimen with unequal doses of anhydrous theophylline (BY158K) is well suited to this population of fast metabolisers. The patients were well protected throughout the day, including the critical early morning hours." @default.
- W2018162564 created "2016-06-24" @default.
- W2018162564 creator A5002899079 @default.
- W2018162564 creator A5016008891 @default.
- W2018162564 creator A5020518654 @default.
- W2018162564 creator A5025129894 @default.
- W2018162564 creator A5026746249 @default.
- W2018162564 creator A5073952726 @default.
- W2018162564 creator A5086339084 @default.
- W2018162564 creator A5087386642 @default.
- W2018162564 date "1987-01-01" @default.
- W2018162564 modified "2023-10-18" @default.
- W2018162564 title "Steady State Pharmacokinetics, Metabolism and Pharmacodynamics of Theophylline in Children After Unequal Twice-Daily Dosing of a New Sustained-Release Formulation" @default.
- W2018162564 cites W1513487015 @default.
- W2018162564 cites W1867824869 @default.
- W2018162564 cites W1965911452 @default.
- W2018162564 cites W1975790353 @default.
- W2018162564 cites W1977320766 @default.
- W2018162564 cites W1980871523 @default.
- W2018162564 cites W1982252291 @default.
- W2018162564 cites W1984138242 @default.
- W2018162564 cites W1984218574 @default.
- W2018162564 cites W2005584393 @default.
- W2018162564 cites W2007998500 @default.
- W2018162564 cites W2036377286 @default.
- W2018162564 cites W2054399459 @default.
- W2018162564 cites W2061446984 @default.
- W2018162564 cites W2075616156 @default.
- W2018162564 cites W2085151404 @default.
- W2018162564 cites W2095396653 @default.
- W2018162564 cites W2126750708 @default.
- W2018162564 cites W2323350502 @default.
- W2018162564 cites W2416957466 @default.
- W2018162564 doi "https://doi.org/10.3109/07420528709083526" @default.
- W2018162564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3677217" @default.
- W2018162564 hasPublicationYear "1987" @default.
- W2018162564 type Work @default.
- W2018162564 sameAs 2018162564 @default.
- W2018162564 citedByCount "9" @default.
- W2018162564 countsByYear W20181625642015 @default.
- W2018162564 countsByYear W20181625642018 @default.
- W2018162564 crossrefType "journal-article" @default.
- W2018162564 hasAuthorship W2018162564A5002899079 @default.
- W2018162564 hasAuthorship W2018162564A5016008891 @default.
- W2018162564 hasAuthorship W2018162564A5020518654 @default.
- W2018162564 hasAuthorship W2018162564A5025129894 @default.
- W2018162564 hasAuthorship W2018162564A5026746249 @default.
- W2018162564 hasAuthorship W2018162564A5073952726 @default.
- W2018162564 hasAuthorship W2018162564A5086339084 @default.
- W2018162564 hasAuthorship W2018162564A5087386642 @default.
- W2018162564 hasConcept C111113717 @default.
- W2018162564 hasConcept C112705442 @default.
- W2018162564 hasConcept C121332964 @default.
- W2018162564 hasConcept C126322002 @default.
- W2018162564 hasConcept C1276947 @default.
- W2018162564 hasConcept C134018914 @default.
- W2018162564 hasConcept C181199279 @default.
- W2018162564 hasConcept C185592680 @default.
- W2018162564 hasConcept C19720800 @default.
- W2018162564 hasConcept C2776042228 @default.
- W2018162564 hasConcept C2776476923 @default.
- W2018162564 hasConcept C2777288759 @default.
- W2018162564 hasConcept C2777477808 @default.
- W2018162564 hasConcept C2778095195 @default.
- W2018162564 hasConcept C2779470414 @default.
- W2018162564 hasConcept C2779765676 @default.
- W2018162564 hasConcept C2779881121 @default.
- W2018162564 hasConcept C2781018748 @default.
- W2018162564 hasConcept C55493867 @default.
- W2018162564 hasConcept C71924100 @default.
- W2018162564 hasConcept C98274493 @default.
- W2018162564 hasConceptScore W2018162564C111113717 @default.
- W2018162564 hasConceptScore W2018162564C112705442 @default.
- W2018162564 hasConceptScore W2018162564C121332964 @default.
- W2018162564 hasConceptScore W2018162564C126322002 @default.
- W2018162564 hasConceptScore W2018162564C1276947 @default.
- W2018162564 hasConceptScore W2018162564C134018914 @default.
- W2018162564 hasConceptScore W2018162564C181199279 @default.
- W2018162564 hasConceptScore W2018162564C185592680 @default.
- W2018162564 hasConceptScore W2018162564C19720800 @default.
- W2018162564 hasConceptScore W2018162564C2776042228 @default.
- W2018162564 hasConceptScore W2018162564C2776476923 @default.
- W2018162564 hasConceptScore W2018162564C2777288759 @default.
- W2018162564 hasConceptScore W2018162564C2777477808 @default.
- W2018162564 hasConceptScore W2018162564C2778095195 @default.
- W2018162564 hasConceptScore W2018162564C2779470414 @default.
- W2018162564 hasConceptScore W2018162564C2779765676 @default.
- W2018162564 hasConceptScore W2018162564C2779881121 @default.
- W2018162564 hasConceptScore W2018162564C2781018748 @default.
- W2018162564 hasConceptScore W2018162564C55493867 @default.
- W2018162564 hasConceptScore W2018162564C71924100 @default.
- W2018162564 hasConceptScore W2018162564C98274493 @default.
- W2018162564 hasIssue "3" @default.
- W2018162564 hasLocation W20181625641 @default.
- W2018162564 hasLocation W20181625642 @default.
- W2018162564 hasOpenAccess W2018162564 @default.
- W2018162564 hasPrimaryLocation W20181625641 @default.
- W2018162564 hasRelatedWork W1963914795 @default.